CD303 (BDCA-2) MicroBead Kit, human

The CD303 (BDCA-2) MicroBead Kit has been developed for convenient isolation of plasmacytoid dendritic cells (PDCs) from tissues (i.e., bone marrow or lymph nodes). For PDC enrichment from blood, the CD304 MicroBead Kit or the (Diamond) PDC Isolation Kit, are recommended.

qualityAssuranceSatisfaction
guaranteed
more »

Related products for CD303 (BDCA-2) MicroBead Kit, human

Product data and images for CD303 (BDCA-2) MicroBead Kit, human
Figure 1

Isolation of CD303 (BDCA-2)+ PDCs from tonsils using the CD303 (BDCA-2) MicroBead Kit, MS Columns, and a MiniMACS™ Separator. Cells were stained with CD304 (BDCA-4/Neuropilin-1)-APC and CD123-PE.

Specifications for CD303 (BDCA-2) MicroBead Kit, human
Overview

The CD303 (BDCA-2) MicroBead Kit has been developed for convenient isolation of plasmacytoid dendritic cells (PDCs) from tissues (i.e., bone marrow or lymph nodes). For PDC enrichment from blood, the CD304 MicroBead Kit or the (Diamond) PDC Isolation Kit, are recommended.

Detailed product information
Background information

Like CD304 (BDCA-4/Neuropilin-1), the CD303 (BDCA-2) antigen1-4 is a specific marker for CD11c– CD123+ plasmacytoid dendritic cells (PDCs) in blood1,3 and bone marrow5. Additionally, CD303 (BDCA-2) expression is strictly confined to PDCs in tissue, e.g., tonsils or lymph nodes3,5. CD303 (BDCA-2) is a novel type II transmembrane C-type lectin3.5. Unlike binding of antibodies to CD304 (BDCA-4), binding of antibodies to CD303 (BDCA-2) inhibits IFN type I production, which is induced in PDCs by, e.g., influenza virus, CpG oligonucleotides, or serum of systemic lupus erythematosus patients3,5,7. Remarkably, PDCs can take up ligand via CD303 (BDCA-2) and process and present ligand to T cells1,3. CD303 (BDCA-2)+ dendritic cells show a plasmacytoid morphology, express the pre-T cell receptor α-chain and are CD4+, CD45RA+, CD304 (BDCA-4/Neuropilin-1)+, CD141 (BDCA-3)dim, CD1c (BDCA-1)–, and CD2–. They lack expression of lineage markers (CD3, CD14, CD16, CD19, CD20, CD56) and express neither myeloid markers such as CD13 and CD33, nor Fc receptors such as CD32, CD64, or FcεRI1.Unlike CD304 (BDCA-4/Neuropilin-1), CD303 (BDCA-2) is not detectable on CD1a+ dendritic cells generated ex vivo from monocytes or hematopoietic precursor cells.

Downstream applications

PDCs were isolated for functional analyses and compared with other dendritic cell subsets.1,3 Furthermore, mRNA was isolated from enriched CD303 (BDCA-2)+ cells for expression cloning of CD303 (BDCA-2)3 or for analyses on expression of DCAL-1 by RT-PCR6. The kit can also be used to deplete CD303 (BDCA-2)+ cells from, e.g., tonsillar cell suspensions8.

Columns

MS, LS, or autoMACS® Columns.

Citations for CD303 (BDCA-2) MicroBead Kit, human
Publications
  1. Audige, A. et al. (2006) Anti-HIV state but not apoptosis depends on IFN signature in CD4+ T cells. J Immunol 177: 6227-6237
  2. Rönnblom, L. and Alm, G. V. (2001) A pivotal role for the natural interferon α-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 194: 59-63
  3. Grabbe, S. et al. (2000) Dendritic cells: multi-lineal and multi-functional. Immunol. Today 21: 431-433
  4. Ryan, E. J. et al. (2002) Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4. J Immunol 169: 5638-5648
  5. Dzionek, A. et al. (2000) BDCA-2, BDCA-3, BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165: 6037-6046
  6. Dzionek, A. et al. (2001) BDCA-2, a novel plasmacytoid dendritic cell–specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction. J. Exp. Med. 194: 1823-1834
  7. Dzionek, A. et al. (2002) Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol 63: 1133-1148
  8. Kerkmann, M. et al. (2003) Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol 170: 4465-4474

You have previously chosen International as your location.
What do you want to do?